Novel Concepts in Epileptogenesis and its Prevention

Neurotherapeutics

Volumn 11, Issue 2, 2014, Pages 229-230

  Jehi, Lara E ^a   Vezzani, Annamaria ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BIOLOGICAL MARKER;

BENIGN CHILDHOOD EPILEPSY; BRAIN TUMOR; COMORBIDITY; CORTICAL DYSPLASIA; DEPRESSION; EDITORIAL; EMOTIONAL DISORDER; EPILEPSY; EPILEPTOGENESIS; EXPERIMENTAL MODEL; HEAD INJURY; HIPPOCAMPAL SCLEROSIS; HUMAN; MEDICAL RESEARCH; NEUROIMAGING; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; PATHOPHYSIOLOGY;

EPILEPSY; HUMANS;

EID: 84899485878     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-014-0268-z     Document Type: Editorial

References (15)

1. World Health Organization. Epilepsy. Fact sheet number 999. October 2012. Available at: http://www. who. int/mediacentre/factsheets/fs999/en/index. html. Accessed May 13, 2013.
2. National Center for Chronic Disease Prevention and Health Promotion. Targeting epilepsy improving the lives of people with one of the nation's most common neurological conditions at a glance 2011. June 6, 2011. Available at: http://www. cdc. gov/chronicdisease/resources/publications/AAG/epilepsy. htm. Accessed May 13, 2013.
3. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21: 718-779.
4. Institute of Medicine, Board on Health Sciences Policy. Epilepsy Across the spectrum: Promoting health and understanding. March 30, 2012. Available at: http://www. iom. edu/Reports/2012/Epilepsy-Across-the-Spectrum. aspx. Accessed June 1, 2012.
5. Pitkänen A, Engel J, Jr. Past and present definitions of epileptogenesis and its biomarkers. Neurotherapeutics 2014.
6. Patterson KP, Baram TZ, Shinnar S. Origins of temporal lobe epilepsy: Febrile seizures and febrile status epilepticus. Neurotherapeutics 2014.
7. Pitkänen A, Immonem R. Epilepsy related to traumatic brain injury. Neurotherapeutics 2014.
8. Guerrini R, Marini C. Genetic epilepsy syndromes without structural brain abnormalities: Clinical features and experimental modes. Neurotherapeutics 2014.
9. Aronica E, Crino PB. Epilepsy related to developmental tumors and malformations of cortical development. Neurotherapeutics 2014.
10. Pardo CA, Nabbout R, Galanopoulou AS. Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile-infection-related epilepsy syndrome (FIRES). Neurotherapeutics 2014.
11. Bien CG, Bauer J. Autoimmune epilepsies. Neurotherapeutics 2014.
12. Kanner, AM, Mazarati A, Koepp M. Biomarkers of epileptogenesis: Psychiatric comorbidities? Neurotherapeutics 2014.
13. White HS, Löscher W. Searching for the ideal antiepileptogenic agent in experimental models: Single treatment versus combinatorial treatment strategies. Neurotherapeutics 2014.
14. Kaminski RM, Rogawski MA, Klitgaard H. The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatments. Neurotherapeutics 2014.
15. Schmidt D, Friedman D, Dichter MA. Anti-epileptogenic clinical trial designs in epilepsy: Issues and options. Neurotherapeutics 2014.